nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0403	0.0879	CbGbCtD
Hydralazine—CYP3A4—Felbamate—epilepsy syndrome	0.0375	0.0817	CbGbCtD
Hydralazine—CYP3A4—Trimethadione—epilepsy syndrome	0.0375	0.0817	CbGbCtD
Hydralazine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0352	0.0768	CbGbCtD
Hydralazine—CYP3A4—Clonazepam—epilepsy syndrome	0.0319	0.0694	CbGbCtD
Hydralazine—CYP3A4—Clobazam—epilepsy syndrome	0.0305	0.0666	CbGbCtD
Hydralazine—CYP3A4—Rufinamide—epilepsy syndrome	0.026	0.0566	CbGbCtD
Hydralazine—CYP3A4—Carbamazepine—epilepsy syndrome	0.0253	0.0552	CbGbCtD
Hydralazine—CYP3A4—Primidone—epilepsy syndrome	0.0236	0.0515	CbGbCtD
Hydralazine—CYP3A4—Phenytoin—epilepsy syndrome	0.0227	0.0495	CbGbCtD
Hydralazine—CYP3A4—Propofol—epilepsy syndrome	0.0212	0.0462	CbGbCtD
Hydralazine—CYP3A4—Phenobarbital—epilepsy syndrome	0.0202	0.0441	CbGbCtD
Hydralazine—CYP3A4—Acetazolamide—epilepsy syndrome	0.0202	0.0441	CbGbCtD
Hydralazine—CYP3A4—Midazolam—epilepsy syndrome	0.0199	0.0435	CbGbCtD
Hydralazine—CYP3A4—Diazepam—epilepsy syndrome	0.0192	0.0418	CbGbCtD
Hydralazine—CYP3A4—Zonisamide—epilepsy syndrome	0.0187	0.0408	CbGbCtD
Hydralazine—CYP3A4—Valproic Acid—epilepsy syndrome	0.0151	0.033	CbGbCtD
Hydralazine—CYP3A4—Topiramate—epilepsy syndrome	0.0136	0.0297	CbGbCtD
Hydralazine—RYR2—hindbrain—epilepsy syndrome	0.0111	0.13	CbGeAlD
Hydralazine—RYR2—brainstem—epilepsy syndrome	0.00635	0.0747	CbGeAlD
Hydralazine—RYR2—forebrain—epilepsy syndrome	0.00613	0.0721	CbGeAlD
Hydralazine—RYR2—telencephalon—epilepsy syndrome	0.00563	0.0663	CbGeAlD
Hydralazine—RYR2—Stimuli-sensing channels—CLCN6—epilepsy syndrome	0.00478	0.0325	CbGpPWpGaD
Hydralazine—RYR2—Stimuli-sensing channels—CLCN2—epilepsy syndrome	0.00478	0.0325	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNG3—epilepsy syndrome	0.00476	0.0324	CbGpPWpGaD
Hydralazine—RYR2—medulla oblongata—epilepsy syndrome	0.00443	0.0521	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNG2—epilepsy syndrome	0.00442	0.0301	CbGpPWpGaD
Hydralazine—RYR2—midbrain—epilepsy syndrome	0.00405	0.0476	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNA2D2—epilepsy syndrome	0.00394	0.0268	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNB4—epilepsy syndrome	0.00394	0.0268	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.00378	0.0257	CbGpPWpGaD
Hydralazine—RYR2—head—epilepsy syndrome	0.00351	0.0413	CbGeAlD
Hydralazine—RYR2—nervous system—epilepsy syndrome	0.00333	0.0391	CbGeAlD
Hydralazine—RYR2—central nervous system—epilepsy syndrome	0.0032	0.0377	CbGeAlD
Hydralazine—RYR2—cerebellum—epilepsy syndrome	0.00313	0.0368	CbGeAlD
Hydralazine—RYR2—Ion channel transport—CLCN2—epilepsy syndrome	0.00312	0.0212	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—CLCN6—epilepsy syndrome	0.00312	0.0212	CbGpPWpGaD
Hydralazine—P4HA1—telencephalon—epilepsy syndrome	0.00271	0.0319	CbGeAlD
Hydralazine—AOC3—medulla oblongata—epilepsy syndrome	0.00266	0.0313	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNA1D—epilepsy syndrome	0.00263	0.0179	CbGpPWpGaD
Hydralazine—RYR2—brain—epilepsy syndrome	0.00254	0.0299	CbGeAlD
Hydralazine—AOC3—midbrain—epilepsy syndrome	0.00244	0.0287	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—epilepsy syndrome	0.00239	0.0163	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—KCNB1—epilepsy syndrome	0.00225	0.0153	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—SLC8A1—epilepsy syndrome	0.00224	0.0152	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.00217	0.0148	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.00217	0.0148	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—SLC8A3—epilepsy syndrome	0.00215	0.0146	CbGpPWpGaD
Hydralazine—P4HA1—medulla oblongata—epilepsy syndrome	0.00213	0.0251	CbGeAlD
Hydralazine—AOC3—head—epilepsy syndrome	0.00211	0.0248	CbGeAlD
Hydralazine—RYR2—Ion channel transport—GABRG2—epilepsy syndrome	0.00201	0.0137	CbGpPWpGaD
Hydralazine—AOC3—nervous system—epilepsy syndrome	0.002	0.0236	CbGeAlD
Hydralazine—P4HA1—midbrain—epilepsy syndrome	0.00195	0.0229	CbGeAlD
Hydralazine—AOC3—central nervous system—epilepsy syndrome	0.00193	0.0227	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GJB6—epilepsy syndrome	0.00191	0.013	CbGpPWpGaD
Hydralazine—RYR2—Stimuli-sensing channels—TRPV1—epilepsy syndrome	0.0019	0.0129	CbGpPWpGaD
Hydralazine—P4HA1—spinal cord—epilepsy syndrome	0.0019	0.0223	CbGeAlD
Hydralazine—AOC3—cerebellum—epilepsy syndrome	0.00188	0.0222	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CDH2—epilepsy syndrome	0.00181	0.0123	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ATP2A2—epilepsy syndrome	0.00172	0.0117	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTB—epilepsy syndrome	0.00169	0.0115	CbGpPWpGaD
Hydralazine—P4HA1—head—epilepsy syndrome	0.00169	0.0199	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.00169	0.0115	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA2—epilepsy syndrome	0.00167	0.0113	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.00165	0.0112	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CACNA1A—epilepsy syndrome	0.00163	0.0111	CbGpPWpGaD
Hydralazine—P4HA1—nervous system—epilepsy syndrome	0.0016	0.0188	CbGeAlD
Hydralazine—P4HA1—central nervous system—epilepsy syndrome	0.00154	0.0181	CbGeAlD
Hydralazine—AOC3—brain—epilepsy syndrome	0.00153	0.018	CbGeAlD
Hydralazine—RYR2—Ion channel transport—GABRA5—epilepsy syndrome	0.00152	0.0104	CbGpPWpGaD
Hydralazine—P4HA1—cerebellum—epilepsy syndrome	0.00151	0.0177	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.0015	0.0102	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.0015	0.0102	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CACNA1D—epilepsy syndrome	0.0015	0.0102	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—ARHGEF9—epilepsy syndrome	0.00146	0.00994	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—GABRA1—epilepsy syndrome	0.00146	0.00994	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—GABRB3—epilepsy syndrome	0.00146	0.00994	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.00145	0.00986	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.0014	0.00952	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GNAO1—epilepsy syndrome	0.00138	0.00942	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CHRM1—epilepsy syndrome	0.00133	0.00903	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—GABRB2—epilepsy syndrome	0.00129	0.00881	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—SLC8A1—epilepsy syndrome	0.00128	0.0087	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—TRPV1—epilepsy syndrome	0.00124	0.00845	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—SLC8A1—epilepsy syndrome	0.00124	0.00842	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CHRM3—epilepsy syndrome	0.00123	0.0084	CbGpPWpGaD
Hydralazine—P4HA1—brain—epilepsy syndrome	0.00122	0.0144	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.00119	0.00809	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.00119	0.00809	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CHRM2—epilepsy syndrome	0.00116	0.0079	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.00112	0.00761	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00109	0.00739	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00109	0.00739	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.001	0.00683	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ATP2A2—epilepsy syndrome	0.00098	0.00667	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000967	0.00658	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000967	0.00658	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000967	0.00658	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ATP2A2—epilepsy syndrome	0.00095	0.00646	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ACTB—epilepsy syndrome	0.000938	0.00638	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—ATP2A2—epilepsy syndrome	0.000917	0.00624	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CRH—epilepsy syndrome	0.000916	0.00624	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—OXT—epilepsy syndrome	0.000916	0.00624	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000912	0.0062	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000885	0.00602	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000848	0.00577	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000824	0.00561	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000824	0.00561	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000821	0.00559	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000773	0.00526	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS1—epilepsy syndrome	0.000759	0.00517	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000755	0.00514	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000733	0.00499	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000733	0.00499	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000733	0.00499	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000699	0.00476	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000699	0.00476	CbGpPWpGaD
Hydralazine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000627	0.00427	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000625	0.00425	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000615	0.00419	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000591	0.00402	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—YWHAZ—epilepsy syndrome	0.000573	0.0039	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000571	0.00389	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.00057	0.00388	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000556	0.00378	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000556	0.00378	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—YWHAZ—epilepsy syndrome	0.000555	0.00378	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000552	0.00376	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000546	0.00372	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000544	0.0037	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.00053	0.00361	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.00052	0.00354	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000508	0.00346	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000508	0.00346	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000508	0.00346	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000508	0.00346	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCB—epilepsy syndrome	0.000473	0.00322	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000472	0.00321	CbGpPWpGaD
Hydralazine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000466	0.00317	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCB—epilepsy syndrome	0.000458	0.00312	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000451	0.00307	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000444	0.00302	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000432	0.00294	CbGpPWpGaD
Hydralazine—CYP3A4—nervous system—epilepsy syndrome	0.000424	0.00499	CbGeAlD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—FOS—epilepsy syndrome	0.000418	0.00284	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000416	0.00283	CbGpPWpGaD
Hydralazine—CYP3A4—central nervous system—epilepsy syndrome	0.000409	0.00481	CbGeAlD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000402	0.00273	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000402	0.00273	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.000401	0.00273	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000389	0.00265	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000385	0.00262	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000358	0.00244	CbGpPWpGaD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000343	0.00234	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000341	0.00232	CbGpPWpGaD
Hydralazine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000333	0.00226	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000327	0.00223	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000319	0.00217	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—epilepsy syndrome	0.00031	0.00211	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.000308	0.0021	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.000307	0.00209	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—JUN—epilepsy syndrome	0.0003	0.00204	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	0.000299	0.00203	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000282	0.00192	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000271	0.00185	CbGpPWpGaD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000268	0.00182	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	0.000261	0.00178	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000259	0.00176	CbGpPWpGaD
Hydralazine—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	0.00025	0.0017	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.00024	0.00163	CbGpPWpGaD
Hydralazine—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	0.000224	0.00152	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	0.000224	0.00152	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000215	0.00147	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000213	0.00145	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000211	0.00144	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000207	0.00141	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000204	0.00139	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000197	0.00134	CbGpPWpGaD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	0.000182	0.00124	CbGpPWpGaD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000182	0.00124	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000181	0.00123	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000171	0.00117	CbGpPWpGaD
Hydralazine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000168	0.000542	CcSEcCtD
Hydralazine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000168	0.000542	CcSEcCtD
Hydralazine—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000168	0.000542	CcSEcCtD
Hydralazine—Vomiting—Propofol—epilepsy syndrome	0.000167	0.00054	CcSEcCtD
Hydralazine—Muscle spasms—Pregabalin—epilepsy syndrome	0.000167	0.000538	CcSEcCtD
Hydralazine—Pruritus—Diazepam—epilepsy syndrome	0.000166	0.000538	CcSEcCtD
Hydralazine—Conjunctivitis—Topiramate—epilepsy syndrome	0.000166	0.000537	CcSEcCtD
Hydralazine—Rash—Propofol—epilepsy syndrome	0.000166	0.000536	CcSEcCtD
Hydralazine—Dermatitis—Propofol—epilepsy syndrome	0.000166	0.000535	CcSEcCtD
Hydralazine—Headache—Propofol—epilepsy syndrome	0.000165	0.000532	CcSEcCtD
Hydralazine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000164	0.000531	CcSEcCtD
Hydralazine—Chills—Gabapentin—epilepsy syndrome	0.000164	0.000529	CcSEcCtD
Hydralazine—Vomiting—Midazolam—epilepsy syndrome	0.000164	0.000529	CcSEcCtD
Hydralazine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000164	0.000528	CcSEcCtD
Hydralazine—Arthralgia—Valproic Acid—epilepsy syndrome	0.000163	0.000527	CcSEcCtD
Hydralazine—Myalgia—Valproic Acid—epilepsy syndrome	0.000163	0.000527	CcSEcCtD
Hydralazine—Haematuria—Topiramate—epilepsy syndrome	0.000163	0.000527	CcSEcCtD
Hydralazine—Anxiety—Valproic Acid—epilepsy syndrome	0.000163	0.000526	CcSEcCtD
Hydralazine—Tremor—Pregabalin—epilepsy syndrome	0.000162	0.000525	CcSEcCtD
Hydralazine—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000162	0.000524	CcSEcCtD
Hydralazine—Rash—Midazolam—epilepsy syndrome	0.000162	0.000524	CcSEcCtD
Hydralazine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000162	0.000524	CcSEcCtD
Hydralazine—Dermatitis—Midazolam—epilepsy syndrome	0.000162	0.000524	CcSEcCtD
Hydralazine—Urticaria—Carbamazepine—epilepsy syndrome	0.000162	0.000523	CcSEcCtD
Hydralazine—Vomiting—Levetiracetam—epilepsy syndrome	0.000162	0.000522	CcSEcCtD
Hydralazine—Discomfort—Valproic Acid—epilepsy syndrome	0.000161	0.000521	CcSEcCtD
Hydralazine—Headache—Midazolam—epilepsy syndrome	0.000161	0.000521	CcSEcCtD
Hydralazine—Pruritus—Felbamate—epilepsy syndrome	0.000161	0.000521	CcSEcCtD
Hydralazine—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000161	0.00052	CcSEcCtD
Hydralazine—Diarrhoea—Diazepam—epilepsy syndrome	0.000161	0.00052	CcSEcCtD
Hydralazine—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000161	0.00052	CcSEcCtD
Hydralazine—Rash—Levetiracetam—epilepsy syndrome	0.00016	0.000518	CcSEcCtD
Hydralazine—Anaemia—Pregabalin—epilepsy syndrome	0.00016	0.000518	CcSEcCtD
Hydralazine—Dermatitis—Levetiracetam—epilepsy syndrome	0.00016	0.000517	CcSEcCtD
Hydralazine—Agranulocytosis—Topiramate—epilepsy syndrome	0.00016	0.000516	CcSEcCtD
Hydralazine—Agitation—Pregabalin—epilepsy syndrome	0.000159	0.000515	CcSEcCtD
Hydralazine—Headache—Levetiracetam—epilepsy syndrome	0.000159	0.000514	CcSEcCtD
Hydralazine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000158	0.000512	CcSEcCtD
Hydralazine—Dizziness—Vigabatrin—epilepsy syndrome	0.000158	0.000511	CcSEcCtD
Hydralazine—Pruritus—Zonisamide—epilepsy syndrome	0.000158	0.00051	CcSEcCtD
Hydralazine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000157	0.000508	CcSEcCtD
Hydralazine—Oedema—Valproic Acid—epilepsy syndrome	0.000156	0.000506	CcSEcCtD
Hydralazine—Urticaria—Lamotrigine—epilepsy syndrome	0.000156	0.000505	CcSEcCtD
Hydralazine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000156	0.000505	CcSEcCtD
Hydralazine—Malaise—Pregabalin—epilepsy syndrome	0.000156	0.000505	CcSEcCtD
Hydralazine—Nausea—Propofol—epilepsy syndrome	0.000156	0.000505	CcSEcCtD
Hydralazine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000156	0.000504	CcSEcCtD
Hydralazine—Diarrhoea—Felbamate—epilepsy syndrome	0.000156	0.000504	CcSEcCtD
Hydralazine—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000156	0.000503	CcSEcCtD
Hydralazine—Dizziness—Diazepam—epilepsy syndrome	0.000156	0.000503	CcSEcCtD
Hydralazine—Leukopenia—Pregabalin—epilepsy syndrome	0.000155	0.000501	CcSEcCtD
Hydralazine—Rash—Fosphenytoin—epilepsy syndrome	0.000155	0.0005	CcSEcCtD
Hydralazine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000154	0.000499	CcSEcCtD
Hydralazine—Headache—Fosphenytoin—epilepsy syndrome	0.000154	0.000496	CcSEcCtD
Hydralazine—Hepatitis—Topiramate—epilepsy syndrome	0.000154	0.000496	CcSEcCtD
Hydralazine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000153	0.000495	CcSEcCtD
Hydralazine—Palpitations—Pregabalin—epilepsy syndrome	0.000153	0.000495	CcSEcCtD
Hydralazine—Nausea—Midazolam—epilepsy syndrome	0.000153	0.000494	CcSEcCtD
Hydralazine—Hallucination—Topiramate—epilepsy syndrome	0.000153	0.000494	CcSEcCtD
Hydralazine—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000153	0.000494	CcSEcCtD
Hydralazine—Muscle spasms—Gabapentin—epilepsy syndrome	0.000153	0.000494	CcSEcCtD
Hydralazine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000153	0.000493	CcSEcCtD
Hydralazine—Diarrhoea—Zonisamide—epilepsy syndrome	0.000153	0.000493	CcSEcCtD
Hydralazine—Pruritus—Clonazepam—epilepsy syndrome	0.000152	0.000491	CcSEcCtD
Hydralazine—Vomiting—Vigabatrin—epilepsy syndrome	0.000152	0.000491	CcSEcCtD
Hydralazine—Pruritus—Phenytoin—epilepsy syndrome	0.000151	0.000488	CcSEcCtD
Hydralazine—Nausea—Levetiracetam—epilepsy syndrome	0.000151	0.000488	CcSEcCtD
Hydralazine—Rash—Vigabatrin—epilepsy syndrome	0.000151	0.000487	CcSEcCtD
Hydralazine—Dizziness—Felbamate—epilepsy syndrome	0.000151	0.000487	CcSEcCtD
Hydralazine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000151	0.000487	CcSEcCtD
Hydralazine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00015	0.000485	CcSEcCtD
Hydralazine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00015	0.000485	CcSEcCtD
Hydralazine—Headache—Vigabatrin—epilepsy syndrome	0.00015	0.000484	CcSEcCtD
Hydralazine—Vomiting—Diazepam—epilepsy syndrome	0.00015	0.000483	CcSEcCtD
Hydralazine—Anorexia—Valproic Acid—epilepsy syndrome	0.000149	0.000482	CcSEcCtD
Hydralazine—Tremor—Gabapentin—epilepsy syndrome	0.000149	0.000481	CcSEcCtD
Hydralazine—Rash—Diazepam—epilepsy syndrome	0.000148	0.000479	CcSEcCtD
Hydralazine—Dermatitis—Diazepam—epilepsy syndrome	0.000148	0.000479	CcSEcCtD
Hydralazine—Myalgia—Pregabalin—epilepsy syndrome	0.000148	0.000477	CcSEcCtD
Hydralazine—Arthralgia—Pregabalin—epilepsy syndrome	0.000148	0.000477	CcSEcCtD
Hydralazine—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000147	0.000476	CcSEcCtD
Hydralazine—Dizziness—Zonisamide—epilepsy syndrome	0.000147	0.000476	CcSEcCtD
Hydralazine—Headache—Diazepam—epilepsy syndrome	0.000147	0.000476	CcSEcCtD
Hydralazine—Anxiety—Pregabalin—epilepsy syndrome	0.000147	0.000475	CcSEcCtD
Hydralazine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000147	0.000475	CcSEcCtD
Hydralazine—Anaemia—Gabapentin—epilepsy syndrome	0.000147	0.000475	CcSEcCtD
Hydralazine—Hypotension—Valproic Acid—epilepsy syndrome	0.000146	0.000472	CcSEcCtD
Hydralazine—Agitation—Gabapentin—epilepsy syndrome	0.000146	0.000472	CcSEcCtD
Hydralazine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000146	0.000472	CcSEcCtD
Hydralazine—Discomfort—Pregabalin—epilepsy syndrome	0.000146	0.000471	CcSEcCtD
Hydralazine—Nausea—Fosphenytoin—epilepsy syndrome	0.000146	0.000471	CcSEcCtD
Hydralazine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000145	0.000469	CcSEcCtD
Hydralazine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000145	0.000469	CcSEcCtD
Hydralazine—Vomiting—Felbamate—epilepsy syndrome	0.000145	0.000468	CcSEcCtD
Hydralazine—Pruritus—Carbamazepine—epilepsy syndrome	0.000144	0.000466	CcSEcCtD
Hydralazine—Rash—Felbamate—epilepsy syndrome	0.000144	0.000464	CcSEcCtD
Hydralazine—Dermatitis—Felbamate—epilepsy syndrome	0.000143	0.000464	CcSEcCtD
Hydralazine—Malaise—Gabapentin—epilepsy syndrome	0.000143	0.000463	CcSEcCtD
Hydralazine—Headache—Felbamate—epilepsy syndrome	0.000143	0.000461	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000143	0.000461	CcSEcCtD
Hydralazine—Flushing—Topiramate—epilepsy syndrome	0.000143	0.000461	CcSEcCtD
Hydralazine—Leukopenia—Gabapentin—epilepsy syndrome	0.000142	0.00046	CcSEcCtD
Hydralazine—Dizziness—Clonazepam—epilepsy syndrome	0.000142	0.000459	CcSEcCtD
Hydralazine—Nausea—Vigabatrin—epilepsy syndrome	0.000142	0.000459	CcSEcCtD
Hydralazine—Vomiting—Zonisamide—epilepsy syndrome	0.000142	0.000458	CcSEcCtD
Hydralazine—Oedema—Pregabalin—epilepsy syndrome	0.000141	0.000457	CcSEcCtD
Hydralazine—Dizziness—Phenytoin—epilepsy syndrome	0.000141	0.000456	CcSEcCtD
Hydralazine—Rash—Zonisamide—epilepsy syndrome	0.000141	0.000454	CcSEcCtD
Hydralazine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.00014	0.000454	CcSEcCtD
Hydralazine—Palpitations—Gabapentin—epilepsy syndrome	0.00014	0.000454	CcSEcCtD
Hydralazine—Dermatitis—Zonisamide—epilepsy syndrome	0.00014	0.000454	CcSEcCtD
Hydralazine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00014	0.000454	CcSEcCtD
Hydralazine—Nausea—Diazepam—epilepsy syndrome	0.00014	0.000452	CcSEcCtD
Hydralazine—Headache—Zonisamide—epilepsy syndrome	0.00014	0.000451	CcSEcCtD
Hydralazine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000139	0.000451	CcSEcCtD
Hydralazine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000139	0.00045	CcSEcCtD
Hydralazine—Pruritus—Lamotrigine—epilepsy syndrome	0.000139	0.00045	CcSEcCtD
Hydralazine—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000138	0.000448	CcSEcCtD
Hydralazine—Tachycardia—Pregabalin—epilepsy syndrome	0.000138	0.000446	CcSEcCtD
Hydralazine—Chills—Topiramate—epilepsy syndrome	0.000138	0.000445	CcSEcCtD
Hydralazine—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000138	0.000445	CcSEcCtD
Hydralazine—Vomiting—Clonazepam—epilepsy syndrome	0.000137	0.000441	CcSEcCtD
Hydralazine—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000136	0.000439	CcSEcCtD
Hydralazine—Vomiting—Phenytoin—epilepsy syndrome	0.000136	0.000438	CcSEcCtD
Hydralazine—Rash—Clonazepam—epilepsy syndrome	0.000135	0.000438	CcSEcCtD
Hydralazine—Dermatitis—Clonazepam—epilepsy syndrome	0.000135	0.000437	CcSEcCtD
Hydralazine—Arthralgia—Gabapentin—epilepsy syndrome	0.000135	0.000437	CcSEcCtD
Hydralazine—Myalgia—Gabapentin—epilepsy syndrome	0.000135	0.000437	CcSEcCtD
Hydralazine—Nausea—Felbamate—epilepsy syndrome	0.000135	0.000437	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000135	0.000436	CcSEcCtD
Hydralazine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000135	0.000436	CcSEcCtD
Hydralazine—Anxiety—Gabapentin—epilepsy syndrome	0.000135	0.000436	CcSEcCtD
Hydralazine—Anorexia—Pregabalin—epilepsy syndrome	0.000135	0.000436	CcSEcCtD
Hydralazine—Dizziness—Carbamazepine—epilepsy syndrome	0.000135	0.000435	CcSEcCtD
Hydralazine—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000135	0.000435	CcSEcCtD
Hydralazine—Headache—Clonazepam—epilepsy syndrome	0.000135	0.000435	CcSEcCtD
Hydralazine—Rash—Phenytoin—epilepsy syndrome	0.000135	0.000435	CcSEcCtD
Hydralazine—Dermatitis—Phenytoin—epilepsy syndrome	0.000134	0.000434	CcSEcCtD
Hydralazine—Rash—Oxcarbazepine—epilepsy syndrome	0.000134	0.000433	CcSEcCtD
Hydralazine—Constipation—Valproic Acid—epilepsy syndrome	0.000134	0.000432	CcSEcCtD
Hydralazine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000134	0.000432	CcSEcCtD
Hydralazine—Headache—Phenytoin—epilepsy syndrome	0.000134	0.000432	CcSEcCtD
Hydralazine—Discomfort—Gabapentin—epilepsy syndrome	0.000134	0.000432	CcSEcCtD
Hydralazine—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000133	0.000908	CbGpPWpGaD
Hydralazine—Headache—Oxcarbazepine—epilepsy syndrome	0.000133	0.00043	CcSEcCtD
Hydralazine—Nausea—Zonisamide—epilepsy syndrome	0.000132	0.000428	CcSEcCtD
Hydralazine—Hypotension—Pregabalin—epilepsy syndrome	0.000132	0.000427	CcSEcCtD
Hydralazine—Dizziness—Lamotrigine—epilepsy syndrome	0.00013	0.000421	CcSEcCtD
Hydralazine—Oedema—Gabapentin—epilepsy syndrome	0.00013	0.000419	CcSEcCtD
Hydralazine—Vomiting—Carbamazepine—epilepsy syndrome	0.00013	0.000419	CcSEcCtD
Hydralazine—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000129	0.000417	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000129	0.000416	CcSEcCtD
Hydralazine—Muscle spasms—Topiramate—epilepsy syndrome	0.000129	0.000415	CcSEcCtD
Hydralazine—Rash—Carbamazepine—epilepsy syndrome	0.000128	0.000415	CcSEcCtD
Hydralazine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000128	0.000415	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000128	0.00087	CbGpPWpGaD
Hydralazine—Nausea—Clonazepam—epilepsy syndrome	0.000128	0.000412	CcSEcCtD
Hydralazine—Headache—Carbamazepine—epilepsy syndrome	0.000128	0.000412	CcSEcCtD
Hydralazine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000127	0.00041	CcSEcCtD
Hydralazine—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000127	0.00041	CcSEcCtD
Hydralazine—Nausea—Phenytoin—epilepsy syndrome	0.000127	0.00041	CcSEcCtD
Hydralazine—Tachycardia—Gabapentin—epilepsy syndrome	0.000127	0.000409	CcSEcCtD
Hydralazine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000126	0.000407	CcSEcCtD
Hydralazine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000126	0.000407	CcSEcCtD
Hydralazine—Tremor—Topiramate—epilepsy syndrome	0.000125	0.000405	CcSEcCtD
Hydralazine—Vomiting—Lamotrigine—epilepsy syndrome	0.000125	0.000405	CcSEcCtD
Hydralazine—Urticaria—Valproic Acid—epilepsy syndrome	0.000124	0.000402	CcSEcCtD
Hydralazine—Rash—Lamotrigine—epilepsy syndrome	0.000124	0.000401	CcSEcCtD
Hydralazine—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000124	0.000401	CcSEcCtD
Hydralazine—Dermatitis—Lamotrigine—epilepsy syndrome	0.000124	0.000401	CcSEcCtD
Hydralazine—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000124	0.0004	CcSEcCtD
Hydralazine—Anorexia—Gabapentin—epilepsy syndrome	0.000124	0.0004	CcSEcCtD
Hydralazine—Anaemia—Topiramate—epilepsy syndrome	0.000124	0.000399	CcSEcCtD
Hydralazine—Headache—Lamotrigine—epilepsy syndrome	0.000123	0.000399	CcSEcCtD
Hydralazine—Decreased appetite—Pregabalin—epilepsy syndrome	0.000123	0.000397	CcSEcCtD
Hydralazine—Agitation—Topiramate—epilepsy syndrome	0.000123	0.000397	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000122	0.000395	CcSEcCtD
Hydralazine—Hypotension—Gabapentin—epilepsy syndrome	0.000121	0.000392	CcSEcCtD
Hydralazine—Nausea—Carbamazepine—epilepsy syndrome	0.000121	0.000391	CcSEcCtD
Hydralazine—Constipation—Pregabalin—epilepsy syndrome	0.000121	0.000391	CcSEcCtD
Hydralazine—Malaise—Topiramate—epilepsy syndrome	0.000121	0.00039	CcSEcCtD
Hydralazine—Leukopenia—Topiramate—epilepsy syndrome	0.00012	0.000387	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000118	0.000382	CcSEcCtD
Hydralazine—Palpitations—Topiramate—epilepsy syndrome	0.000118	0.000382	CcSEcCtD
Hydralazine—Nausea—Lamotrigine—epilepsy syndrome	0.000117	0.000378	CcSEcCtD
Hydralazine—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000117	0.000377	CcSEcCtD
Hydralazine—Paraesthesia—Gabapentin—epilepsy syndrome	0.000116	0.000376	CcSEcCtD
Hydralazine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000116	0.000374	CcSEcCtD
Hydralazine—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000115	0.000372	CcSEcCtD
Hydralazine—Dyspepsia—Gabapentin—epilepsy syndrome	0.000114	0.000369	CcSEcCtD
Hydralazine—Myalgia—Topiramate—epilepsy syndrome	0.000114	0.000368	CcSEcCtD
Hydralazine—Arthralgia—Topiramate—epilepsy syndrome	0.000114	0.000368	CcSEcCtD
Hydralazine—Anxiety—Topiramate—epilepsy syndrome	0.000113	0.000367	CcSEcCtD
Hydralazine—Decreased appetite—Gabapentin—epilepsy syndrome	0.000113	0.000364	CcSEcCtD
Hydralazine—Discomfort—Topiramate—epilepsy syndrome	0.000112	0.000363	CcSEcCtD
Hydralazine—Urticaria—Pregabalin—epilepsy syndrome	0.000112	0.000363	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000112	0.000362	CcSEcCtD
Hydralazine—Body temperature increased—Pregabalin—epilepsy syndrome	0.000112	0.000361	CcSEcCtD
Hydralazine—Constipation—Gabapentin—epilepsy syndrome	0.000111	0.000358	CcSEcCtD
Hydralazine—Pruritus—Valproic Acid—epilepsy syndrome	0.000111	0.000358	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.00011	0.000747	CbGpPWpGaD
Hydralazine—Oedema—Topiramate—epilepsy syndrome	0.000109	0.000353	CcSEcCtD
Hydralazine—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000107	0.000346	CcSEcCtD
Hydralazine—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000107	0.000345	CcSEcCtD
Hydralazine—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000107	0.000345	CcSEcCtD
Hydralazine—Tachycardia—Topiramate—epilepsy syndrome	0.000106	0.000344	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000105	0.000712	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000104	0.00071	CbGpPWpGaD
Hydralazine—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000104	0.000337	CcSEcCtD
Hydralazine—Anorexia—Topiramate—epilepsy syndrome	0.000104	0.000336	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000104	0.000706	CbGpPWpGaD
Hydralazine—Dizziness—Valproic Acid—epilepsy syndrome	0.000103	0.000334	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000103	0.000701	CbGpPWpGaD
Hydralazine—Urticaria—Gabapentin—epilepsy syndrome	0.000103	0.000333	CcSEcCtD
Hydralazine—Body temperature increased—Gabapentin—epilepsy syndrome	0.000103	0.000331	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000102	0.000696	CbGpPWpGaD
Hydralazine—Hypotension—Topiramate—epilepsy syndrome	0.000102	0.000329	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000102	0.000692	CbGpPWpGaD
Hydralazine—Pruritus—Pregabalin—epilepsy syndrome	0.0001	0.000323	CcSEcCtD
Hydralazine—Vomiting—Valproic Acid—epilepsy syndrome	9.95e-05	0.000321	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.94e-05	0.000321	CcSEcCtD
Hydralazine—Rash—Valproic Acid—epilepsy syndrome	9.86e-05	0.000319	CcSEcCtD
Hydralazine—Dermatitis—Valproic Acid—epilepsy syndrome	9.85e-05	0.000318	CcSEcCtD
Hydralazine—Headache—Valproic Acid—epilepsy syndrome	9.8e-05	0.000317	CcSEcCtD
Hydralazine—Paraesthesia—Topiramate—epilepsy syndrome	9.8e-05	0.000317	CcSEcCtD
Hydralazine—Dyspnoea—Topiramate—epilepsy syndrome	9.73e-05	0.000314	CcSEcCtD
Hydralazine—Diarrhoea—Pregabalin—epilepsy syndrome	9.68e-05	0.000313	CcSEcCtD
Hydralazine—Dyspepsia—Topiramate—epilepsy syndrome	9.6e-05	0.00031	CcSEcCtD
Hydralazine—Hypersensitivity—Gabapentin—epilepsy syndrome	9.55e-05	0.000309	CcSEcCtD
Hydralazine—Decreased appetite—Topiramate—epilepsy syndrome	9.48e-05	0.000307	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.42e-05	0.000304	CcSEcCtD
Hydralazine—Dizziness—Pregabalin—epilepsy syndrome	9.35e-05	0.000302	CcSEcCtD
Hydralazine—Constipation—Topiramate—epilepsy syndrome	9.33e-05	0.000302	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	9.3e-05	0.000633	CbGpPWpGaD
Hydralazine—Nausea—Valproic Acid—epilepsy syndrome	9.29e-05	0.0003	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	9.18e-05	0.000625	CbGpPWpGaD
Hydralazine—Pruritus—Gabapentin—epilepsy syndrome	9.17e-05	0.000297	CcSEcCtD
Hydralazine—Vomiting—Pregabalin—epilepsy syndrome	8.99e-05	0.000291	CcSEcCtD
Hydralazine—Feeling abnormal—Topiramate—epilepsy syndrome	8.99e-05	0.000291	CcSEcCtD
Hydralazine—Rash—Pregabalin—epilepsy syndrome	8.92e-05	0.000288	CcSEcCtD
Hydralazine—Dermatitis—Pregabalin—epilepsy syndrome	8.91e-05	0.000288	CcSEcCtD
Hydralazine—Diarrhoea—Gabapentin—epilepsy syndrome	8.87e-05	0.000287	CcSEcCtD
Hydralazine—Headache—Pregabalin—epilepsy syndrome	8.86e-05	0.000286	CcSEcCtD
Hydralazine—Urticaria—Topiramate—epilepsy syndrome	8.67e-05	0.00028	CcSEcCtD
Hydralazine—Body temperature increased—Topiramate—epilepsy syndrome	8.62e-05	0.000279	CcSEcCtD
Hydralazine—Dizziness—Gabapentin—epilepsy syndrome	8.58e-05	0.000277	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	8.44e-05	0.000574	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	8.4e-05	0.000572	CbGpPWpGaD
Hydralazine—Nausea—Pregabalin—epilepsy syndrome	8.4e-05	0.000271	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	8.35e-05	0.000568	CbGpPWpGaD
Hydralazine—Vomiting—Gabapentin—epilepsy syndrome	8.25e-05	0.000266	CcSEcCtD
Hydralazine—Rash—Gabapentin—epilepsy syndrome	8.18e-05	0.000264	CcSEcCtD
Hydralazine—Dermatitis—Gabapentin—epilepsy syndrome	8.17e-05	0.000264	CcSEcCtD
Hydralazine—Headache—Gabapentin—epilepsy syndrome	8.12e-05	0.000263	CcSEcCtD
Hydralazine—Hypersensitivity—Topiramate—epilepsy syndrome	8.04e-05	0.00026	CcSEcCtD
Hydralazine—Pruritus—Topiramate—epilepsy syndrome	7.72e-05	0.000249	CcSEcCtD
Hydralazine—Nausea—Gabapentin—epilepsy syndrome	7.7e-05	0.000249	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.54e-05	0.000513	CbGpPWpGaD
Hydralazine—Diarrhoea—Topiramate—epilepsy syndrome	7.46e-05	0.000241	CcSEcCtD
Hydralazine—Dizziness—Topiramate—epilepsy syndrome	7.21e-05	0.000233	CcSEcCtD
Hydralazine—Vomiting—Topiramate—epilepsy syndrome	6.94e-05	0.000224	CcSEcCtD
Hydralazine—Rash—Topiramate—epilepsy syndrome	6.88e-05	0.000222	CcSEcCtD
Hydralazine—Dermatitis—Topiramate—epilepsy syndrome	6.87e-05	0.000222	CcSEcCtD
Hydralazine—Headache—Topiramate—epilepsy syndrome	6.83e-05	0.000221	CcSEcCtD
Hydralazine—Nausea—Topiramate—epilepsy syndrome	6.48e-05	0.000209	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.56e-05	0.00031	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.46e-05	0.000304	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.44e-05	0.000302	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.4e-05	0.0003	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.38e-05	0.000298	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	4e-05	0.000273	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.95e-05	0.000269	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.69e-05	0.000251	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.05e-05	0.000208	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.31e-05	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.31e-05	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.31e-05	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.31e-05	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.31e-05	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.31e-05	0.000158	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.12e-05	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.12e-05	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.12e-05	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.12e-05	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.97e-05	0.000134	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.97e-05	0.000134	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.96e-05	0.000134	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.85e-05	0.000126	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.75e-05	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.75e-05	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.75e-05	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.75e-05	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.75e-05	0.000119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.6e-05	0.000109	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.6e-05	0.000109	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.6e-05	0.000109	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.54e-05	0.000105	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.49e-05	0.000101	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.49e-05	0.000101	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.4e-05	9.54e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.36e-05	9.28e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.33e-05	9.05e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.33e-05	9.05e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.27e-05	8.63e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.27e-05	8.63e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.24e-05	8.45e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.22e-05	8.27e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.19e-05	8.11e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.17e-05	7.96e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.09e-05	7.45e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.06e-05	7.23e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.61e-06	6.54e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.61e-06	6.54e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.83e-06	5.33e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.63e-06	5.2e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.59e-06	5.16e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.85e-06	4.66e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.52e-06	4.44e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.49e-06	4.42e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.19e-06	4.21e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.13e-06	4.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TH—epilepsy syndrome	6.1e-06	4.15e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.09e-06	3.47e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.03e-06	3.42e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.89e-06	3.33e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.55e-06	3.09e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.99e-06	2.71e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.91e-06	2.66e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.35e-06	2.28e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.06e-06	2.08e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.68e-06	1.82e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.34e-06	9.15e-06	CbGpPWpGaD
